毕得医药跌11.15% 2022上市超募8.7亿海通证券保荐

中国经济网
28 Mar

中国经济网北京3月28日讯 毕得医药(688073.SH)今日收报47.98元,跌幅11.15%,总市值43.61亿元。目前该股处于破发状态。  毕得医药于2022年10月11日在上交所科创板上市,发行股票数量为1,622.9100万股,发行价格为88.00元/股。公司的保荐机构为海通证券股份有限公司,保荐代表人杨阳、雷浩。  公司上市发行募集资金总额142,816.08万元;扣除发行费用后,募集...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10